Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Docetaxel + Telmisartan |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Docetaxel | Taxotere | RP56976 | Antimicrotubule Agent 14 | Taxotere (docetaxel) binds to tubulin, inhibiting microtubule disassembly and preventing cell division (PMID: 32496783, PMID: 32366558). |
| Telmisartan | BIBR 277|Micardis | Telmisartan is a AT1R antagonist that also acts as a PPARG agonist to inhibit IL-6 expression, potentially resulting in decreased tumor cell proliferation (PMID: 39032472). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06815497 | Phase II | Docetaxel + Telmisartan Paclitaxel + Telmisartan Nab-paclitaxel + Telmisartan Doxorubicin + Telmisartan Pegylated liposomal doxorubicin + Telmisartan | Telmisartan in Combination with Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer | Not yet recruiting | USA | 0 |